Abstract
NEONATAL CARE UNIT ANTIBIOTIC THERAPY IN THE CHILDREN WELFARE TEACHING HOSPITAL

*Aamer J. Alsudani, Firas H. Qamber and Sanna N. Muhamed Hasan

ABSTRACT

Background: Antibiotics are commonly used medication in neonatal care units (NCU) as sepsis regard the main cause of neonatal morbidity and mortality, especially in preterm infants. Consequently, practitioners in NCU have to use empirical antibiotics. Frequently prescribe empirical antibiotics while awaiting culture results. Unfortunately, use of broad-spectrum antibiotics or prolonged treatment of empirical antibiotics may result in adverse effects including the emergence of antibiotic resistance microorganisms, prolonged hospitalization and increased cost. Narrow-spectrum antibiotics are effective in common neonatal pathogens. The aim of this study is to evaluate the implementing strategies for wise and scientific use of antibiotics. A cross-sectional method was performed to during the period from 1st of April 2017 to 28th of February 2018 in neonatal care (NCU) ward in Child Welfare Teaching Hospital. Results revealed that the most admitted neonates were male 66%, age of neonates at admission time mostly ≥7 days(67.5%) and around 64% with CRP positive, regard duration of treatment mostly more than 14 days(42.5%). Pathogens isolated 51.2% Staphylococcus aureus, streptococcus spp. 17.5% and acinatobacter boumania 15% respectively. Antimicrobial prescribed Carbapenems(Meropenem) 40%, Glycopeptides(Vancomycin) 37.5% and Aminoglycosides (Amikacin) 17.5%. Antibiotics are commonly prescribed in NICU and are lifesaving in most of a serious infection, in the other hand overuse of antibiotics has potential risk of negative effects to neonates. Conclusions: Most neonatal pathogens isolated by cultures are susceptible to narrow-spectrum antibiotics and common. There is high consumption of broad spectrum antibiotics in the NCU.

Keywords: Antibiotic; Empirical; Neonatal care unit; microorganisms; Infection; culture.


[Full Text Article]

Login





Forgot Password  |  Register

Indexing

Best Paper Awards

European Journal of Biomedical and Pharmaceutical Sciences (EJBPS) will give best paper award in every issue in the form of money along with certificate to promote research activity of scholar.

Best Article of current issue :

Tangudu Nagabhusana Rao

Download Article : Click here

News & Updation

  • OCTOBER ISSUE PUBLISHED

    OCTOBER 2018 Issue has been successfully launched on 1 October 2018

  • EJBPS New Impact Factor

    Its our Pleasure to Inform you that EJBPS Impact Factor has been increased from 4.382 to 4.918 due to high quality Publication at International Level.

  • Index Copernicus Value

    EJBPS Received Index Copernicus Value 77.3, due to High Quality Publication in EJBPS at International Level

  • Journal web site support Internet Explorer, Google Chrome, Mozilla Firefox, Opera, Saffari for easy download of article without any trouble.

    .

  • Article Invited for Publication

    Dear Researcher, Article Invited for Publication  in EJBPS coming Issue.

     

UG/PG/Ph.D Research Publication

Research Scholar of UG/PG/Ph.D can Submit their Research Article/Review Article/Case Study/Short Communication for Publication in EJBPS

Downloads

Copyright From

Covering Letter

                        Author Instruction 
 

PLAGERLUM REPORT